JAZZ Earnings Jazz Pharmaceuticals Plc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 4.43 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -5.84 | 2026-02-24 | 10-K |
| Q3 2025 | 2025-09-30 | -9.18 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -13.28 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.52 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | 8.65 | 2026-02-24 | 10-K |
| Q3 2025 | 2024-09-30 | 5.63 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | 2.35 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.23 | 2025-05-07 | 10-Q |
| FY 2025 | 2023-12-31 | 6.10 | 2026-02-24 | 10-K |
| Q3 2024 | 2023-09-30 | 4.67 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | 2.55 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | 1.04 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | -3.58 | 2025-02-26 | 10-K |
| Q3 2023 | 2022-09-30 | 0.26 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.57 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.03 | 2023-05-10 | 10-Q |
| FY 2023 | 2021-12-31 | -5.52 | 2024-02-28 | 10-K |
| Q3 2022 | 2021-09-30 | -4.98 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -4.17 | 2022-08-03 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.